Cargando…

Hybrid, metal oxide-peptide amphiphile micelles for molecular magnetic resonance imaging of atherosclerosis

BACKGROUND: Atherosclerosis, a major source of cardiovascular disease, is asymptomatic for decades until the activation of thrombosis and the rupture of enlarged plaques, resulting in acute coronary syndromes and sudden cardiac arrest. Magnetic resonance imaging (MRI) is a noninvasive nuclear imagin...

Descripción completa

Detalles Bibliográficos
Autores principales: Poon, Christopher, Gallo, Juan, Joo, Johan, Chang, Timothy, Bañobre-López, Manuel, Chung, Eun Ji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6238287/
https://www.ncbi.nlm.nih.gov/pubmed/30442135
http://dx.doi.org/10.1186/s12951-018-0420-8
_version_ 1783371344130342912
author Poon, Christopher
Gallo, Juan
Joo, Johan
Chang, Timothy
Bañobre-López, Manuel
Chung, Eun Ji
author_facet Poon, Christopher
Gallo, Juan
Joo, Johan
Chang, Timothy
Bañobre-López, Manuel
Chung, Eun Ji
author_sort Poon, Christopher
collection PubMed
description BACKGROUND: Atherosclerosis, a major source of cardiovascular disease, is asymptomatic for decades until the activation of thrombosis and the rupture of enlarged plaques, resulting in acute coronary syndromes and sudden cardiac arrest. Magnetic resonance imaging (MRI) is a noninvasive nuclear imaging technique to assess the degree of atherosclerotic plaque with high spatial resolution and excellent soft tissue contrast. However, MRI lacks sensitivity for preventive medicine, which limits the ability to observe the onset of vulnerable plaques. In this study, we engineered hybrid metal oxide-peptide amphiphile micelles (HMO-Ms) that combine an inorganic, magnetic iron oxide or manganese oxide inner core with organic, fibrin-targeting peptide amphiphiles, consisting of the sequence CREKA, for potential MRI imaging of thrombosis on atherosclerotic plaques. RESULTS: Hybrid metal oxide-peptide amphiphile micelles, consisting of an iron oxide (Fe-Ms) or manganese oxide (Mn-Ms) core with CREKA peptides, were self-assembled into 20–30 nm spherical nanoparticles, as confirmed by dynamic light scattering and transmission electron microscopy. These hybrid nanoparticles were found to be biocompatible with human aortic endothelial cells in vitro, and HMO-Ms bound to human clots three to five times more efficiently than its non-targeted counterparts. Relaxivity studies showed ultra-high r(2) value of 457 mM(−1) s(−1) and r(1) value of 0.48 mM(−1) s(−1) for Fe-Ms and Mn-Ms, respectively. In vitro, MR imaging studies demonstrated the targeting capability of CREKA-functionalized hybrid nanoparticles with twofold enhancement of MR signals. CONCLUSION: This novel hybrid class of MR agents has potential as a non-invasive imaging method that specifically detects thrombosis during the pathogenesis of atherosclerosis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12951-018-0420-8) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6238287
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-62382872018-11-23 Hybrid, metal oxide-peptide amphiphile micelles for molecular magnetic resonance imaging of atherosclerosis Poon, Christopher Gallo, Juan Joo, Johan Chang, Timothy Bañobre-López, Manuel Chung, Eun Ji J Nanobiotechnology Research BACKGROUND: Atherosclerosis, a major source of cardiovascular disease, is asymptomatic for decades until the activation of thrombosis and the rupture of enlarged plaques, resulting in acute coronary syndromes and sudden cardiac arrest. Magnetic resonance imaging (MRI) is a noninvasive nuclear imaging technique to assess the degree of atherosclerotic plaque with high spatial resolution and excellent soft tissue contrast. However, MRI lacks sensitivity for preventive medicine, which limits the ability to observe the onset of vulnerable plaques. In this study, we engineered hybrid metal oxide-peptide amphiphile micelles (HMO-Ms) that combine an inorganic, magnetic iron oxide or manganese oxide inner core with organic, fibrin-targeting peptide amphiphiles, consisting of the sequence CREKA, for potential MRI imaging of thrombosis on atherosclerotic plaques. RESULTS: Hybrid metal oxide-peptide amphiphile micelles, consisting of an iron oxide (Fe-Ms) or manganese oxide (Mn-Ms) core with CREKA peptides, were self-assembled into 20–30 nm spherical nanoparticles, as confirmed by dynamic light scattering and transmission electron microscopy. These hybrid nanoparticles were found to be biocompatible with human aortic endothelial cells in vitro, and HMO-Ms bound to human clots three to five times more efficiently than its non-targeted counterparts. Relaxivity studies showed ultra-high r(2) value of 457 mM(−1) s(−1) and r(1) value of 0.48 mM(−1) s(−1) for Fe-Ms and Mn-Ms, respectively. In vitro, MR imaging studies demonstrated the targeting capability of CREKA-functionalized hybrid nanoparticles with twofold enhancement of MR signals. CONCLUSION: This novel hybrid class of MR agents has potential as a non-invasive imaging method that specifically detects thrombosis during the pathogenesis of atherosclerosis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12951-018-0420-8) contains supplementary material, which is available to authorized users. BioMed Central 2018-11-15 /pmc/articles/PMC6238287/ /pubmed/30442135 http://dx.doi.org/10.1186/s12951-018-0420-8 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Poon, Christopher
Gallo, Juan
Joo, Johan
Chang, Timothy
Bañobre-López, Manuel
Chung, Eun Ji
Hybrid, metal oxide-peptide amphiphile micelles for molecular magnetic resonance imaging of atherosclerosis
title Hybrid, metal oxide-peptide amphiphile micelles for molecular magnetic resonance imaging of atherosclerosis
title_full Hybrid, metal oxide-peptide amphiphile micelles for molecular magnetic resonance imaging of atherosclerosis
title_fullStr Hybrid, metal oxide-peptide amphiphile micelles for molecular magnetic resonance imaging of atherosclerosis
title_full_unstemmed Hybrid, metal oxide-peptide amphiphile micelles for molecular magnetic resonance imaging of atherosclerosis
title_short Hybrid, metal oxide-peptide amphiphile micelles for molecular magnetic resonance imaging of atherosclerosis
title_sort hybrid, metal oxide-peptide amphiphile micelles for molecular magnetic resonance imaging of atherosclerosis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6238287/
https://www.ncbi.nlm.nih.gov/pubmed/30442135
http://dx.doi.org/10.1186/s12951-018-0420-8
work_keys_str_mv AT poonchristopher hybridmetaloxidepeptideamphiphilemicellesformolecularmagneticresonanceimagingofatherosclerosis
AT gallojuan hybridmetaloxidepeptideamphiphilemicellesformolecularmagneticresonanceimagingofatherosclerosis
AT joojohan hybridmetaloxidepeptideamphiphilemicellesformolecularmagneticresonanceimagingofatherosclerosis
AT changtimothy hybridmetaloxidepeptideamphiphilemicellesformolecularmagneticresonanceimagingofatherosclerosis
AT banobrelopezmanuel hybridmetaloxidepeptideamphiphilemicellesformolecularmagneticresonanceimagingofatherosclerosis
AT chungeunji hybridmetaloxidepeptideamphiphilemicellesformolecularmagneticresonanceimagingofatherosclerosis